ES8600299A1 - Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina - Google Patents

Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina

Info

Publication number
ES8600299A1
ES8600299A1 ES537665A ES537665A ES8600299A1 ES 8600299 A1 ES8600299 A1 ES 8600299A1 ES 537665 A ES537665 A ES 537665A ES 537665 A ES537665 A ES 537665A ES 8600299 A1 ES8600299 A1 ES 8600299A1
Authority
ES
Spain
Prior art keywords
furo
vinyl
pyridine derivatives
diuretic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537665A
Other languages
English (en)
Spanish (es)
Other versions
ES537665A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of ES537665A0 publication Critical patent/ES537665A0/es
Publication of ES8600299A1 publication Critical patent/ES8600299A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES537665A 1983-11-16 1984-11-15 Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina Expired ES8600299A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838330517A GB8330517D0 (en) 1983-11-16 1983-11-16 6-vinyl-furo-(3,4-c)pyridine derivatives

Publications (2)

Publication Number Publication Date
ES537665A0 ES537665A0 (es) 1985-09-16
ES8600299A1 true ES8600299A1 (es) 1985-09-16

Family

ID=10551816

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537665A Expired ES8600299A1 (es) 1983-11-16 1984-11-15 Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina

Country Status (25)

Country Link
US (1) US4569939A (en:Method)
JP (1) JPS60112793A (en:Method)
AT (1) AT391867B (en:Method)
BE (1) BE900942A (en:Method)
CA (1) CA1257271A (en:Method)
CH (1) CH660738A5 (en:Method)
DE (1) DE3442035A1 (en:Method)
DK (1) DK157870C (en:Method)
DZ (1) DZ701A1 (en:Method)
ES (1) ES8600299A1 (en:Method)
FI (1) FI79852C (en:Method)
FR (2) FR2554719B1 (en:Method)
GB (2) GB8330517D0 (en:Method)
HK (1) HK36087A (en:Method)
IE (1) IE58005B1 (en:Method)
IT (1) IT1213246B (en:Method)
LU (1) LU85635A1 (en:Method)
MA (1) MA20259A1 (en:Method)
MY (1) MY101721A (en:Method)
NL (1) NL8403353A (en:Method)
OA (1) OA07864A (en:Method)
PT (1) PT79511B (en:Method)
SE (1) SE458116B (en:Method)
SG (1) SG6687G (en:Method)
ZA (1) ZA848130B (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
DE59203008D1 (de) * 1991-04-24 1995-08-31 Ciba Geigy Ag Fliessfähige wässrige Dispersionen von Polycarbonsäure-Korrosionsinhibitoren.
DK1169322T3 (da) 1999-03-08 2006-03-06 Medicure Inc Pyridoxalanaloger til behandling af lidelser foranlediget af vitamin B6-mangel
AU5840200A (en) * 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
ES2305994T3 (es) 2000-02-29 2008-11-01 Medicure International Inc. Fosfonatos cardioprotectores.
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
AU2005304220A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (en:Method) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
IE58005B1 (en) 1993-06-02
ATA364384A (de) 1990-06-15
SG6687G (en) 1987-06-05
IE842930L (en) 1985-05-16
FI844279L (fi) 1985-05-17
SE8405710L (sv) 1985-05-17
ES537665A0 (es) 1985-09-16
FR2554817B1 (fr) 1986-04-18
DK157870C (da) 1990-08-06
OA07864A (fr) 1986-11-20
JPS60112793A (ja) 1985-06-19
ZA848130B (en) 1985-06-26
DE3442035A1 (de) 1985-05-30
FR2554719A1 (fr) 1985-05-17
US4569939A (en) 1986-02-11
GB8426490D0 (en) 1984-11-28
FI79852B (fi) 1989-11-30
FR2554719B1 (fr) 1986-06-06
MA20259A1 (fr) 1985-07-01
IT8423565A0 (it) 1984-11-14
LU85635A1 (fr) 1985-06-04
MY101721A (en) 1992-01-17
DZ701A1 (fr) 2004-09-13
FI844279A0 (fi) 1984-11-01
DK157870B (da) 1990-02-26
FR2554817A1 (fr) 1985-05-17
AT391867B (de) 1990-12-10
JPH0314315B2 (en:Method) 1991-02-26
SE458116B (sv) 1989-02-27
NL8403353A (nl) 1985-06-17
IT1213246B (it) 1989-12-14
CH660738A5 (fr) 1987-06-15
CA1257271A (en) 1989-07-11
GB8330517D0 (en) 1983-12-21
DK542584D0 (da) 1984-11-15
PT79511B (en) 1986-09-08
BE900942A (fr) 1985-02-15
DK542584A (da) 1985-05-17
FI79852C (fi) 1990-03-12
HK36087A (en) 1987-05-08
SE8405710D0 (sv) 1984-11-14
GB2149782B (en) 1986-10-22
GB2149782A (en) 1985-06-19
PT79511A (en) 1984-12-01

Similar Documents

Publication Publication Date Title
ES8600299A1 (es) Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina
IE810108L (en) IMIDAZO £1,2-a| PYRIDINES
PT78751B (en) Preparation process of 2-pyrimidinyl-1-piperazine derivatives and medicines containing them
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
ES8406477A1 (es) Procedimiento para la preparacion de b-carbolinas
ES8600300A1 (es) Procedimiento para preparar nuevos derivados de 1, 3-dihidro-6-metilfuro-(3, 4-c)-piridina
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
ES8503685A1 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
HK48890A (en) Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
ATE30159T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung ausgehend von einem stamm von mikroorganismen, der neue stamm streptomyces cyaneus und die verwendung der anthracyclinderivate als pharmazeutische praeparate.
HK10489A (en) 6-aminomethyl-furo-(3,4-c)-pyridine derivatives
MY103601A (en) New 6-aminomethyl-furo-(3,4-c)-pyridine derivatives their preparation and therapeutic compositions containing the same
JPS5384992A (en) Production of thiazolo(3,2-a)-1,3,5-triazine-4-oxo-2-thione derivative
AU635463B2 (en) 2-amino-t trahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical compositions containing same
HUT34982A (en) Process for the production of new rifamycin hydrazone derivatives, as well as of pharmaceutical preparations containing them
JPS5223069A (en) Preparation of 3-substituted-pyrrole derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201